EX-10.1
from 8-K
186 pages
Credit Agreement Dated as of September 30, 2025 Among Alnylam Pharmaceuticals, Inc., as the Parent Borrower, Bank of America, N.A., as Administrative Agent and Collateral Agent, the Lenders Party Hereto, Bofa Securities, Inc., Jpmorgan Chase Bank, N.A., Goldman Sachs Bank USA and Wells Fargo Securities, LLC as Joint Lead Arrangers and Joint Bookrunners and Citibank, N.A., Morgan Stanley Senior Funding, Inc. and PNC Bank, National Association as Co-Documentation Agents
12/34/56
EX-10.3
from 10-Q
153 pages
Credit Agreement Dated as of April 10, 2020 Among Alnylam Pharmaceuticals, Inc., as the Borrower, the Guarantors From Time to Time Party Hereto, as the Guarantors, the Lenders From Time to Time Party Hereto and Wilmington Trust, National Association, as Administrative Agent
12/34/56
EX-10.3
from 10-Q
61 pages
Credit Agreement Dated as of April 29, 2016 Among Alnylam U.S., Inc., as the Borrower, Alnylam Pharmaceuticals, Inc., as Parent and Parent Guarantor, and Wells Fargo Bank, National Association, as the Lender
12/34/56
EX-10.2
from 10-Q
61 pages
Credit Agreement Dated as of April 29, 2016 Among Alnylam U.S., Inc., as the Borrower, Alnylam Pharmaceuticals, Inc., as Parent and Parent Guarantor, and Bank of America, N.A., as the Lender
12/34/56
EX-10.1
from 8-K
2 pages
Amendment No. 02 Dated June 20, 2005 to That Certain Loan and Security Agreement No. 3861 Dated as of March 26, 2004, as Amended (“Agreement”) by and Between Lighthouse Capital Partners V, L.P. (“Lender”) and Alnylam Pharmaceuticals, Inc., (“Borrower”)
12/34/56
